Several cross-sectional studies have suggested that circulating osteocalcin is negatively associated with ALT, aspartate transaminase, fatty liver index and NAFLD (11, 34–37). This evidence concerns the gene BGLAP and metabolic dysfunction-associated steatotic liver disease.